182 results
8-K
EX-99.1
ACGN
Aceragen Inc
13 Sep 18
Idera Pharmaceuticals Announces Corporate Organizational Changes
12:00am
General Counsel of Incyte Corporation. Prior to Incyte, Mr. Lim held roles of increasing responsibility at ViroPharma Incorporated, Merck & Co., Inc … departure. Mr. Kirby has been with Idera since 2015 and previously held positions of increasing responsibility at Endo Pharmaceuticals, ViroPharma
CORRESP
6qtv4h81dg8 15
16 Jan 13
Correspondence with SEC
12:00am
8-K
EX-99.1
kvc1433m5 swpsg
15 Feb 00
Current report
12:00am
8-K
EX-10.1
h9kgjf9rbw 98dd
5 Jan 21
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
jzg9 vemcz1e462b
9 Jan 14
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases
12:00am
8-K
EX-99.1
p5alghqa
2 Nov 18
Departure of Directors or Certain Officers
8:31am
8-K/A
meqnk
9 Dec 22
Other Events
4:49pm
8-K
EX-99.1
x11ecpaj 16q
17 Nov 20
Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
4:20pm